Form 4: RedHill Biopharma COO Sells Shares
Insider Transaction (Form 4)
Gilead Raday, Chief Operating Officer of RedHill Biopharma Ltd., sold 14,130,000 shares of common stock on July 10, 2026 for $0.00 per share.
Summary
- Open-market sale: disposed of 14,130,000 Ordinary Shares at $0.00 ($1,413) on July 10, 2026; holds 218,780,000 after (Direct).
- Option exercise/conversion: acquired 28,150,000 American Depositary Shares on July 10, 2026; holds 104,130,000 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $1,413 of stock on the open market.
Insider Transactions
Gilead Raday — Officer (Chief Operating Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-10 | Open-market sale | Ordinary Shares | 14,130,000 | $0 | $1.4K | 218,780,000 |
| 2026-07-10 | Option exercise/conversion | American Depositary Shares | 28,150,000 | — | — | 104,130,000 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-10 | Open-market sale (14,130,000 shares) |
| 2026-07-10 | Option exercise/conversion (28,150,000 shares) |
Keywords
insider transaction, Form 4, RDHL, RedHill Biopharma Ltd., bearish, Gilead Raday
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.